ArticleScientific reports2025
An effective PO-RSNN and FZCIS based diabetes prediction and stroke analysis in the metaverse environment.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Retraction · 2026-06-03Computer-Aided Content or Computer-Generated Content · Concerns/Issues about Data · Investigation by Journal/Publisher · Objections by Author(s) · Unreliable Results and/or Conclusions ·
- Retracted
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic disease (CD) like diabetes and stroke impacts global healthcare extensively, and continuous monitoring and early detection are necessary for effective management. The Metaverse Environment (ME) has gained attention in the digital healthcare environment; yet, it lacks adequate support for disabled individuals, including deaf and dumb people, and also faces challenges in security, generalizability, and feature selection. To overcome these limitations, a novel probabilistic-centric optimized recurrent sechelliott neural network (PO-RSNN)-based diabetes prediction (DP) and Fuzzy Z-log-clipping inference system (FZCIS)-based severity level estimation in ME is carried out. The proposed system integrates Montwisted-Jaco curve cryptography (MJCC) for secured data transmission, Aransign-principal component analysis (A-PCA) for feature dimensionality reduction, and synthetic minority oversampling technique (SMOTE) to address data imbalance. The diagnosed results are securely stored in the BlockChain (BC) for enhanced privacy and traceability. The experimental validation demonstrated the superior performance of the proposed system by achieving 98.97% accuracy in DP and 98.89% accuracy in stroke analysis, outperforming existing classifiers. Also, the proposed MJCC technique attained 98.92% efficiency, surpassing the traditional encryption models. Thus, the proposed system produces a secure, scalable, and highly accurate DP and stroke analysis in ME. Further, the research will extend the approach to other CD like cancer and heart disease to improve the predictive performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.